VOR ▲ +1.7% - Vor Biopharma Inc.
$VOR - Telitacicept Demonstrates Durable Preservation of Kidney Function Through Two Years in Phase 3 TELIGAN Trial in IgA Nephropathy
22-OCT-2026 04:05 PM ET
Share this post
More filings for $VOR
VOR ▲ +1.8% - Vor Biopharma Inc.Sep 29, 2026VOR ▼ -0.4% - Vor Biopharma Inc.Sep 8, 2026VOR ▲ +3.2% - Vor Biopharma Inc.Sep 4, 2026VOR ▲ +2.6% - Vor Biopharma Inc.Sep 1, 2026VOR - Vor Biopharma Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026VOR - Vor Biopharma Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $VOR filing history →💬 Comments
Loading comments…
Leave a comment